The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

Abbott (NYSE:ABT) today unveiled a new initiative addressing the biases and stigmas associated with diabetes management.

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they ...

Daewoong Pharmaceutical launches thynC remote patient monitoring with insurance coverage Innovative remote monitoring system ...

Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its ...

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...

Abbott is already a big player in the wearable glucose-monitoring sector ... of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured above), and a prototype version ...

Healthcare costs in the U.S. continue to rise, making it difficult for millions of people to afford essential medical ...

For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...

During her time at CNET, Kim Wong-Shing loved demystifying the world of wellness to make it accessible to any reader. She was also passionate about exploring the intersections of health, history ...